Published in Can Urol Assoc J on March 04, 2015
A critical analysis of the 2014 CUA guidelines for erectile dysfunction: Is there more that can be done? Can Urol Assoc J (2015) 0.75
Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction. Transl Androl Urol (2017) 0.75
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol (2010) 3.55
The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Arch Intern Med (2006) 2.16
Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. Ann Intern Med (2009) 1.53
Diagnostic tests for male erectile dysfunction revisited. Committee Consensus Report of the International Consultation in Sexual Medicine. J Sex Med (2010) 1.44
Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2010) 1.42
PDE5 inhibitors: considerations for preference and long-term adherence. Int J Clin Pract (2013) 1.14
Implants, mechanical devices, and vascular surgery for erectile dysfunction. J Sex Med (2010) 1.08
Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound. J Sex Med (2012) 0.96
SOP: physical examination and laboratory testing for men with erectile dysfunction. J Sex Med (2012) 0.88
A review of outcomes of an intracavernosal injection therapy programme. BJU Int (2012) 0.88
Predictive correlation between the International Index of Erectile Function (IIEF) and Sexual Health Inventory for Men (SHIM): implications for calculating a derived SHIM for clinical use. J Sex Med (2007) 0.87
A practical guide to diagnosis, management and treatment of testosterone deficiency for Canadian physicians. Can Urol Assoc J (2010) 0.85
SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med (2013) 0.84
Standard operating procedures for neurophysiologic assessment of male sexual dysfunction. J Sex Med (2013) 0.83
The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician. Int J Clin Pract (2013) 0.83
Synergetic effect of testosterone and phophodiesterase-5 inhibitors in hypogonadal men with erectile dysfunction: A systematic review. Can Urol Assoc J (2012) 0.82
Impact of a first treatment with phosphodiesterase inhibitors on men and partners' quality of sexual life: results of a prospective study in primary care. J Sex Med (2013) 0.82
Diagnosing erectile dysfunction could save your patient's life. Can Urol Assoc J (2014) 0.80
SOP: corpus cavernosum assessment (cavernosography/cavernosometry). J Sex Med (2012) 0.80
Combination of psychological intervention and phosphodiesterase-5 inhibitors for erectile dysfunction: a narrative review and meta-analysis. J Sex Med (2014) 0.80
Erectile dysfunction practice guidelines. Can J Urol (2002) 0.80
Erectile dysfunction. Can J Diabetes (2013) 0.78
Nocturnal penile erections: the role of RigiScan in the diagnosis of vascular erectile dysfunction. J Sex Med (2012) 0.78